Viromed Medical AG (Q11) — Capital Reinvestment Ratio

Latest as of December 2024: 4.82x

Viromed Medical AG (Q11) has a Capital Reinvestment Ratio of 4.82x as of December 2024, meaning it reinvests 5% of its operating cash flow (€7.45 Million) in capital expenditures (€35.91 Million). See Viromed Medical AG balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

4.82x

Capex / Operating Cash Flow

Operating Cash Flow

€7.45 Million

EUR

Capital Expenditures

€35.91 Million

EUR

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Viromed Medical AG (None–None)

Year-by-year Capital Reinvestment Ratio for Viromed Medical AG from None to None. For live market cap and broader valuation context, see market value of Viromed Medical AG.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow